<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02109198</url>
  </required_header>
  <id_info>
    <org_study_id>CN-NINM pilot</org_study_id>
    <nct_id>NCT02109198</nct_id>
  </id_info>
  <brief_title>Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Trial)</brief_title>
  <official_title>Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Pilot Phase)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>U.S. Army Medical Research and Development Command</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>US Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Defense and Veterans Brain Injury Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>U.S. Army Medical Research and Development Command</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the feasibility of combining PoNS therapy with&#xD;
      standard vestibular and balance therapy with the proposed double-blind design; evaluate&#xD;
      preliminary indications of efficacy. This study is also evaluating recruitment rate,&#xD;
      completion rate, device usability, and outcome measures feasibility.&#xD;
&#xD;
        -  Goal for recruitment: 100% of 30 subjects meeting all inclusion criteria can be&#xD;
           recruited over the 36 week pilot recruitment phase.&#xD;
&#xD;
        -  Completion and compliance: 90% of subjects will complete the study, 90% of sessions&#xD;
           within each subject will be completed, and for completing subjects, 100% of measures&#xD;
           will be completed.&#xD;
&#xD;
        -  Useability: all therapists and subjects must rate useability as good or better.&#xD;
&#xD;
        -  Success of blind: subject accuracy at guessing group membership must be at or near 50%.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    protocol withdrawn&#xD;
  </why_stopped>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>36 weeks</time_frame>
    <description>Number and percentage of subjects recruited over the 36 week pilot recruitment phase</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion and compliance rates</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>Number and percentage of subjects who complete the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Usability rating</measure>
    <time_frame>12 weeks</time_frame>
    <description>Number and percentage of subjects and therapists who rated usability as good or better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Success of blinding</measure>
    <time_frame>12 weeks</time_frame>
    <description>Number and percentage of subjects who accurately guess group membership</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Sensory Organization Test (SOT)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Comparison of the SOT score between the treatment group and sham group at the intermediate follow-up.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Mild Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Active CN-NINM PoNS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active CN-NINM PoNS - Active cranial-nerve non-invasive neuromodulation (CN-NINM) using the Portable Neuromodulation Stimulator (PoNS) and balance/gait rehabilitation with physical therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham PoNS CN-NINM</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham CN-NINM PoNS - Sham cranial-nerve non-invasive neuromodulation (CN-NINM) using the Portable Neuromodulation Stimulator (PoNS) and balance/gait rehabilitation with physical therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active CN-NINM PoNS</intervention_name>
    <description>Delivery of active stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.</description>
    <arm_group_label>Active CN-NINM PoNS</arm_group_label>
    <other_name>Active cranial-nerve non-invasive neuromodulation (CN-NINM)</other_name>
    <other_name>Portable Neuromodulation Stimulator (PoNS)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham CN-NINM PoNS</intervention_name>
    <description>Delivery of sham stimulation of the tongue during in-person therapy sessions (1 hour) and during two home sessions (40 minutes) daily on 6 of 7 days per week (120 total sessions). Stimulation sessions will be separated by at least 4 hours.</description>
    <arm_group_label>Sham PoNS CN-NINM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Veteran or Servicemember&#xD;
&#xD;
          2. 18 to 50 years old&#xD;
&#xD;
          3. Sustained one or more mild traumatic brain injury (mTBI)s&#xD;
&#xD;
          4. Demonstration of balance deficits on the Sensory Organization Test (a composite score&#xD;
             of 75 or less (1/3 sample) and 72 or less (2/3 sample))&#xD;
&#xD;
          5. Available for the duration of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of traumatic brain injury (TBI) of any severity other than mild TBI&#xD;
&#xD;
          2. Presence of active substance abuse condition&#xD;
&#xD;
          3. Any condition for which posturography is contraindicated (e.g. leg amputation or&#xD;
             fracture)&#xD;
&#xD;
          4. Diagnosed neurological disorder with balance sequelae, other than TBI (e.g.&#xD;
             Parkinson's disease, incomplete spinal cord injury, or Multiple Sclerosis)&#xD;
&#xD;
          5. Orthostatic hypotension as defined by:&#xD;
&#xD;
               1. A systolic blood pressure decrease (from supine to sitting) of at least 20 mmHg&#xD;
&#xD;
               2. A diastolic blood pressure decrease of at least 10 mmHg, or&#xD;
&#xD;
               3. A pulse increase of 30 beats or more per minute with associated signs or symptoms&#xD;
                  of cerebral hypoperfusion&#xD;
&#xD;
          6. An implanted medical device&#xD;
&#xD;
          7. Pregnancy&#xD;
&#xD;
          8. Oral infection&#xD;
&#xD;
          9. Known transmissible disease (HIV, hepatitis, influenza, TB)&#xD;
&#xD;
         10. Exam signs of serious disorder other than mTBI as defined by facial asymmetry,&#xD;
             hoarseness and dysarthria (e.g. tumor, stroke).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David X Cifu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Department of Physical Medicine and Rehabilitation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William C Walker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University (VCU)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McGuire Veterans Affairs Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298-3038</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2014</study_first_posted>
  <last_update_submitted>May 29, 2015</last_update_submitted>
  <last_update_submitted_qc>May 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mild Traumatic Brain Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

